COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Kinaset Therapeutics is a clinical-stage biopharma company developing novel inhaled therapies for severe respiratory diseases, led by its pan-JAK inhibitor frevecitinib for asthma.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
